Article info

other Versions

PDF

Cost effectiveness of endosonography versus surgical staging in potentially resectable lung cancer: a health economics analysis of the ASTER trial from a European perspective

Authors

  1. Correspondence to Prof Linda Sharples, MRC Biostatistics Unit Cambridge, Institute of Public Health, University Forvie Site, Robinson Way, Cambridge CB2 0SR, UK; linda.sharples{at}mrc-bsu.cam.ac.uk
View Full Text

Citation

Rintoul RC, Glover MJ, Jackson C, et al
Cost effectiveness of endosonography versus surgical staging in potentially resectable lung cancer: a health economics analysis of the ASTER trial from a European perspective

Publication history

  • Received August 19, 2013
  • Accepted September 5, 2013
  • First published September 24, 2013.

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.